Immune Modulation Template v1
approvedv1.0.0immune modulation · support immune balance · approved by martin@gettetonlabs.com
Provider-only template. Not patient-visible. Dosing is source-attributed or a justified provider override. Approval requires safety + monitoring summaries; high/critical safety rules require acknowledgment.
💉 Dosing schedule
All component dosing in one place — verbatim from source or a justified provider override. Not a recommendation. Edit per component below.
| Component | Dose | Route | Frequency | Duration | Cycle | Source |
|---|---|---|---|---|---|---|
| TA1primary | 1.5 mg SC twice weekly, or 450-900 mcg daily | subcutaneous | twice weekly, or daily | 4-12 weeks | Repeat course per provider direction | Practitioner Peptide Dosing Reference (commonly published ranges)Provider-reviewed |
| Reconstitution: Reconstitute with sterile/bacteriostatic water | ||||||
| LL-37support | 100 mcg SC daily or every other day | subcutaneous | daily or every other day | 2-4 weeks | Short cycles; reassess | Practitioner Peptide Dosing Reference (commonly published ranges)Provider-reviewed |
| Reconstitution: Reconstitute with bacteriostatic water | ||||||
| Vladonixoptional | 1-2 capsules daily (commonly 2 capsules daily) | oral | once or twice daily | 20-30 day course | Repeat course 1-2x per year | Practitioner Peptide Dosing Reference (commonly published ranges)Provider-reviewed |
| Reconstitution: Not applicable (oral capsule) | ||||||
Template details
Components
3TA1primarysrc: Practitioner Peptide Dosing Reference (commonly published ranges)
LL-37supportsrc: Practitioner Peptide Dosing Reference (commonly published ranges)
Vladonixoptionalsrc: Practitioner Peptide Dosing Reference (commonly published ranges)
Safety rules
- high · Recent autoimmune flare may affect immune-modulating safety. (require review)
- caution · LL-37 may aggravate mast-cell/high-reactivity patients. (require acknowledgment)
Monitoring requirements
- lab · Immune markers · Per provider
Evidence links
Audit history (2)
- 2026-06-14 19:46:53 · approve_template by martin@gettetonlabs.com — Approved per provider instruction
- 2026-06-14 19:38:39 · create_template by seed-pack-v1 — Seed Pack v1 (draft)